ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    27 Months Follow Up of a Cohort in the Transplant Continuum After Using a New Electronic Medical Record Tool to Document Transplant Option Discussions Among Patients with EGFR <20 Ml/min/1.73m2

    A. A. Yishak1, M. S. Bhatnagar2, A. V. Tomimatsu3, R. La Londe4, E. Clark5, K. B. Rubenstein6, S. Vupputuri6

    1MAPMG, McLean, VA, 2Kaiser Permanente |, Oakland, CA, 3Kaiser Permanente, Oakland, CA, 4Kaiser Permanente, Oakland,, CA, 5Kaiser Permanente, Hyattsville, MD, 6MAPRI, Rockville, MD

    *Purpose: The purpose of this study was to assess: 1) the documentation of transplant option discussions; 2) the number of members listed & transplanted preemptively;…
  • 2021 American Transplant Congress

    The Development and Characterization of AT1501, an Anti CD40L Antibody Lacking Fc Effector Function

    S. Perrin1, A. Gill2, C. Gill2, F. Vieira2, K. Thompson2, J. Lincecum2, B. Jiang2

    1Novus Therapeutics, Irvine, CA, 2ALS Therapy Development Institute, Cambridge, MA

    *Purpose: CD40L is a costimulatory type II membrane receptor for CD40. The binding of CD40L on T helper cells to CD40 on antigen presenting cells…
  • 2021 American Transplant Congress

    Versatile Strategy to Enhance Nanomedicine Delivery to Graft Endothelial Cells

    C. Albert1, L. G. Bracaglia1, A. Koide2, J. DiRito1, T. Lysyy1, C. Edwards1, J. T. Langford1, D. Haakinson1, S. A. Hosgood3, M. L. Nicholson3, J. S. Pober1, W. M. Saltzman1, S. Kiode2, G. Tietjen1

    1Yale University, new haven, CT, 2Perlmutter Cancer Center, New York University, Langone Medical Center, New York, NY, 3University of Cambridge, Cambridge, United Kingdom

    *Purpose: Efficient delivery of therapeutics to graft endothelial cells (EC) can potentially render organs more resistant to injury, improving clinical outcomes. Specific targeting of polymeric…
  • 2021 American Transplant Congress

    IFNγ, and to a Lesser Extent TNFα, Elicits Protracted Endothelial Cell Expression of Costimulatory Molecules and Antigen Presentation Machinery

    N. M. Valenzuela

    Pathology and Laboratory Medicine, UCLA, Los Angeles, CA

    *Purpose: Beyond simply “recruiting” leukocytes to sites of injury, local stimulation by the donor vascular compartment may prolong alloimmune responses. Moreover, the dynamics of endothelial…
  • 2021 American Transplant Congress

    Influence of Immunosuppressive Drug Trough Levels on Nk Cells in Liver Transplantation

    R. Qin1, J. Qin2, C. Sun3, B. Nashan1

    1Clinic for Organ Transplantation, The First Affiliated Hospital of the University of Science and Technology of China, Hefei, China, 2Clinic for Organ Transplantation, The First Affiliated Hospital of the University of Science and Technology of China., Hefei, China, 3Division of Life and Medicine, University of Science and Technology of China, Hefei, China

    *Purpose: Natural killer (NK) cells are enriched in lymphocytes within the liver and are considered to be main regulators of liver transplantation (LT) rejection and…
  • 2021 American Transplant Congress

    Distinct Phenotype and Function of Antibody-suppressor Cxcr5+Cd8+ T Cells

    J. Zimmerer, J. Han, M. Hart, S. Chaudhari, C. Peterson, G. Bumgardner

    OSU, Columbus, OH

    *Purpose: We have reported that the novel subset of antibody-suppressor CD8+ T cells (termed CD8+ TAb-supp cells) require the expression of CXCR5. In addition, alloprimed…
  • 2021 American Transplant Congress

    LacripepTM-like Peptide N-104 Increases Insulin Secretion and Promotes Islet Transplantation Outcomes

    M. Ma, P. Chhabra, K. Dias Teixeira, G. Laurie, K. Brayman

    University of Virginia Health System, Charlottesville, VA

    *Purpose: To study if LacripepTM-like peptide N-104 promotes beta-cell stabilization and islet transplantation outcomes. Background: Lacritin is a multifunctional tear protein with prosecretory, prosurvival and…
  • 2021 American Transplant Congress

    Sigma-1 Receptor Agonists are Renoprotective in Experimental Kidney Transplantation

    A. Hosszu1, T. Lakat1, A. Toth1, D. Balogh1, J. Hodrea1, L. J. Wagner2, A. J. Szabo1, A. Fekete1

    11st Department of Pediatrics, Semmelweis University, Budapest, Hungary, 2Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

    *Purpose: Kidney transplantation (Tx) is associated with better quality of life and reduced costs compared to dialysis, but the shortage in donor organs is a…
  • 2021 American Transplant Congress

    Characterization of Kidney Small Extracellular Vesicles Released During Normothermic Machine Perfusion

    W. W. Woud1, A. Arykbaeva2, D. de Vries2, I. Alwayn2, K. Boer1, C. Baan1, M. Hoogduijn1, R. Minnee3

    1Internal Medicine, Nephorology and Transplantation, Erasmus MC, Rotterdam, Netherlands, 2Department of Surgery, LUMC, Leiden, Netherlands, 3Department of Surgery, Division of Hepato-Pancreato-Biliary and Transplant Surgery, Erasmus MC, Rotterdam, Netherlands

    *Purpose: By characterizing and quantifying the dynamical release of kidney Extracellular Vesicles (EVs) during Normothermic Machine Perfusion (NMP), we aim to gain a better understanding…
  • 2021 American Transplant Congress

    Longitudinal Surveillance, Relative Change Value (RCV) Improve Diagnostic Test Accuracy (DTA) of Donor-Derived Cell Free DNA (dd-cfDNA)

    S. Anand, F. Lopez-Verdugo, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas

    Intermountain Medical Center, Murray, UT

    *Purpose: dd-cfDNA, an injury biomarker in kidney transplant (KTx), is emerging as a trigger for biopsy (Bx) and superior to the traditional trigger of change…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences